Landscape → Cardiovascular

Thrombosis

167 clinical trials

51 active

167 total (since 2015)

Phase 1 Active

15 total

Phase 2 Active

35 total

Phase 3 Active

66 total

Phase 4 Active

58 total

Top Sponsors (Industry)

Sorted by active Active Done Failed

Regeneron 3 2 0

Boston Scientific Corporation 1 1 0

Anthos Therapeutics, Inc. 1 0 1

Supergene, LLC 1 1 0

Quercis Pharma AG 1 0 0

Sirius Therapeutics Co., Ltd. 1 0 0

Daiichi Sankyo 0 3 1

NCT07432529 NOT YET RECRUITING

Design and Rationale of the COLT Study

Azienda Sanitaria Locale ASL 6, Livorno n=940

NCT07015905 RECRUITING

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Regeneron Pharmaceuticals n=2,000

NCT07140211 RECRUITING

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Marc Blondon n=9,200

NCT07005024 RECRUITING

DOAC - Dosing Options in AntiCoagulation Prophylaxis

University of Vermont n=996

NCT07213778 RECRUITING

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Regeneron Pharmaceuticals n=2,000

NCT06861088 RECRUITING

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Quercis Pharma AG n=480

NCT06393868 RECRUITING

Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism

Ottawa Hospital Research Institute n=360

NCT04319627 RECRUITING

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Ottawa Hospital Research Institute n=2,700

NCT06440694 RECRUITING

Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

Ottawa Hospital Research Institute n=150

NCT05171075 ACTIVE NOT RECRUITING

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Anthos Therapeutics, Inc. n=417

NCT06628778 NOT YET RECRUITING

Collaborative Risk-stratified Investigation in Teen Inpatients With Critical Illness: Anticoagulation With LMWH in Kids for ThromboProphylaxis (CRITICAL-Kids-TP)

Johns Hopkins All Children's Hospital n=802

NCT06195540 RECRUITING

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

University Hospital, Angers n=1,424

NCT06362746 RECRUITING

Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism

Supergene, LLC n=486

NCT07228663 NOT YET RECRUITING

Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention

McMaster University n=100

NCT06580223 NOT YET RECRUITING

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology n=530

NCT05920343 RECRUITING

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Ottawa Hospital Research Institute n=120

NCT05029063 RECRUITING

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

Ottawa Hospital Research Institute n=1,828

NCT05591118 RECRUITING

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

NYU Langone Health n=500

NCT04430569 RECRUITING

Pulmonary Embolism International THrOmbolysis Study-3

Assistance Publique - Hôpitaux de Paris n=800

NCT06453876 NOT YET RECRUITING

Percutaneous Embolectomy, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Jesper Kjaergaard n=210

NCT06494878 NOT YET RECRUITING

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

University of Calgary n=8,805

NCT06611319 RECRUITING

ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty

Prof. Stavros Konstantinides, MD n=2,932

NCT04088292 ACTIVE NOT RECRUITING

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Rigshospitalet, Denmark n=210

NCT06662253 NOT YET RECRUITING

Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial

Alexandre Tran n=150

NCT04257487 RECRUITING

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

Arianna Anticoagulazione Foundation n=1,455

NCT04066764 RECRUITING

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Second Affiliated Hospital, School of Medicine, Zhejiang University n=200

NCT04075240 RECRUITING

VTE Prevention Following Total Hip and Knee Arthroplasty

Sudeep Shivakumar n=5,400

NCT04981327 NOT YET RECRUITING

The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis

University Hospital, Geneva n=1,300

NCT05171049 TERMINATED

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Anthos Therapeutics, Inc. n=1,150

NCT03634124 COMPLETED

Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs

Centre Hospitalier Universitaire de Nīmes n=146

NCT07124819 COMPLETED

Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin

Avexima Diol LLC n=215

NCT03045406 COMPLETED

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

Fadoi Foundation, Italy n=1,170

NCT03080883 COMPLETED

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Academic and Community Cancer Research United n=370

NCT04688320 COMPLETED

Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE

Supergene, LLC n=310

NCT05033314 TERMINATED

THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)

University Health Network, Toronto n=4

NCT02798471 COMPLETED

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Daiichi Sankyo n=290

NCT03506815 COMPLETED

Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines

Ottawa Hospital Research Institute n=105

NCT05104229 WITHDRAWN

SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery

Stefan Holubar MD MS FACS, FASCRS

NCT05946811 WITHDRAWN

Macitentan to Prevent PRVO

University of Maryland, Baltimore

NCT04670432 COMPLETED

Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis

Maastricht University Medical Center n=44

NCT02604238 WITHDRAWN

Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism

Azienda U.S.L. 1 di Massa e Carrara

NCT03285438 COMPLETED

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.

University Hospital, Brest n=2,774

NCT02829957 COMPLETED

RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

Indiana University n=19

NCT05878899 COMPLETED

Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial

University Hospital, Geneva n=77

NCT04248868 COMPLETED

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden

Thrombolex, Inc. n=109

NCT03090880 TERMINATED

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)

Assistance Publique - Hôpitaux de Paris n=59

NCT05515120 COMPLETED

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Instituto Mexicano del Seguro Social n=58

NCT04003116 COMPLETED

Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE)

Ministry of Health, Spain n=70

NCT02555111 COMPLETED

Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.

Assistance Publique - Hôpitaux de Paris n=112

NCT02379806 COMPLETED

The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study

University Hospital, Brest n=2,560

NCT04400799 TERMINATED

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

University of Zurich n=475

NCT04662684 COMPLETED

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial

Science Valley Research Institute n=320

NCT03055026 COMPLETED

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.

Fadoi Foundation, Italy n=582

NCT05185804 COMPLETED

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

PharmaDiall Ltd. n=399

NCT02774265 COMPLETED

A Different Approach to Preventing Thrombosis

University of Maryland, Baltimore n=329

NCT05172115 TERMINATED

Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE

Rajaie Cardiovascular Medical and Research Center n=94

NCT02583191 TERMINATED

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

AIO-Studien-gGmbH n=246

NCT03966079 COMPLETED

Thrombolysis Endovascular Treatment of Pulmonary Embolism

Beijing Tsinghua Chang Gung Hospital n=50

NCT02585713 COMPLETED

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Academic and Community Cancer Research United n=300

NCT02935530 COMPLETED

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Huazhong University of Science and Technology n=315

NCT02073682 COMPLETED

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo n=1,046

NCT02746185 COMPLETED

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

Assistance Publique - Hôpitaux de Paris n=159

NCT02767232 WITHDRAWN

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

University of Colorado, Denver

NCT02920125 COMPLETED

Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.

Sujata Vaidya n=96

NCT01308528 COMPLETED

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

Cristália Produtos Químicos Farmacêuticos Ltda. n=243

NCT02368314 COMPLETED

A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

Biocad n=124

NCT06038630 RECRUITING

129Xe MRI Cardiopulmonary

Bastiaan Driehuys

NCT05683808 RECRUITING

Venous Thromboembolism Prevention in Outpatients With Glioma

University of Vermont Medical Center

NCT07140523 RECRUITING

A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA

Sirius Therapeutics Co., Ltd.

NCT06299111 ACTIVE NOT RECRUITING

A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)

Regeneron Pharmaceuticals

NCT04295486 RECRUITING

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

University of Miami

NCT05794165 ENROLLING BY INVITATION

Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism

Bryan Cotton

NCT06454630 COMPLETED

A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

Regeneron Pharmaceuticals

NCT06149520 COMPLETED

A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis

Bayer

NCT05618808 COMPLETED

A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Regeneron Pharmaceuticals

NCT06220123 COMPLETED

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Beijing Suncadia Pharmaceuticals Co., Ltd

NCT04504318 COMPLETED

Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

Stanford University

NCT05752461 COMPLETED

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Beijing Suncadia Pharmaceuticals Co., Ltd

NCT04996667 WITHDRAWN

Effect of INO in Patients with Submassive and Massive PE

University of California, Los Angeles

NCT04243122 COMPLETED

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

Ottawa Hospital Research Institute

NCT03339349 COMPLETED

Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma

University of Utah

NCT03297359 TERMINATED

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Ottawa Hospital Research Institute

NCT02901067 TERMINATED

STAT-STatin and Aspirin in Trauma

Denver Health and Hospital Authority

NCT02923115 COMPLETED

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

Daiichi Sankyo

NCT04041843 COMPLETED

Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism

New York Medical College

NCT03108833 COMPLETED

A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism

Tasly Biopharmaceuticals Co., Ltd.

NCT04106700 TERMINATED

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Instituto de Investigacion Sanitaria La Fe

NCT03812328 COMPLETED

Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement

Tetherex Pharmaceuticals Corporation

NCT03212365 COMPLETED

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

University of Utah

NCT03251963 COMPLETED

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

University of Utah

NCT02366871 COMPLETED

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

University of Colorado, Denver

NCT03200613 TERMINATED

Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury

McMaster University

NCT03195010 TERMINATED

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Fred Hutchinson Cancer Center

NCT03316729 WITHDRAWN

DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE)

Daiichi Sankyo

NCT02411292 COMPLETED

Enoxaparin Metabolism in Reconstructive Surgery Patients

University of Utah

NCT02334007 COMPLETED

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

McMaster University

NCT02309411 COMPLETED

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis

Bayer

NCT04790370 ACTIVE NOT RECRUITING

Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism

Boston Scientific Corporation

NCT07303816 NOT YET RECRUITING

Statins to Prevent Cancer Associated Blood Clots

Brigham and Women's Hospital

NCT07250763 ACTIVE NOT RECRUITING

Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital

Inova Health Care Services

NCT07189897 RECRUITING

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Kiranya Arnold

NCT03244020 ENROLLING BY INVITATION

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

NCT06581965 RECRUITING

inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

Leiden University Medical Center

NCT04263038 RECRUITING

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Drahomir Aujesky

NCT06603870 RECRUITING

Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

Ottawa Hospital Research Institute

NCT06523959 RECRUITING

Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial

Clinical Urology and Epidemiology Working Group

NCT06845423 RECRUITING

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

University Hospital, Brest

NCT03129555 ACTIVE NOT RECRUITING

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)

Herlev and Gentofte Hospital

NCT06958588 RECRUITING

Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis

Science Valley Research Institute

NCT05735639 RECRUITING

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Imperial College London

NCT03581877 ACTIVE NOT RECRUITING

Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

Northwell Health

NCT06452342 NOT YET RECRUITING

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study

University Health Network, Toronto

NCT05493163 RECRUITING

Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism

Faculty Hospital Kralovske Vinohrady

NCT02810704 COMPLETED

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

Dartmouth-Hitchcock Medical Center

NCT02559856 COMPLETED

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study

Ottawa Hospital Research Institute

NCT03266783 COMPLETED

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Ottawa Hospital Research Institute

NCT04168203 COMPLETED

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Brigham and Women's Hospital

NCT03988101 COMPLETED

Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

Yonsei University

NCT04710732 TERMINATED

Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.

Pirogov Russian National Research Medical University

NCT02464969 COMPLETED

Apixaban for the Acute Treatment of Venous Thromboembolism in Children

Bristol-Myers Squibb

NCT06635317 COMPLETED

Efficacy of Aspirin in Preventing Venous Thromboembolism

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

NCT04794569 TERMINATED

Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome

Sunnybrook Health Sciences Centre

NCT04409834 COMPLETED

Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial

The TIMI Study Group

NCT02945280 TERMINATED

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

Intermountain Health Care, Inc.

NCT04373707 COMPLETED

Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19

Central Hospital, Nancy, France

NCT02474212 COMPLETED

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

Tampere University Hospital

NCT04635839 COMPLETED

Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)

University of California, Los Angeles

NCT04947514 COMPLETED

Use of Tranexamic Acid in Reduction Mammoplasty

Montefiore Medical Center

NCT03678506 TERMINATED

Apixaban for Extended Anticoagulation (APIDULCIS)

Arianna Anticoagulazione Foundation

NCT02856295 COMPLETED

anti10a Levels in Women Treated With LMWH in the Postpartum Period

HaEmek Medical Center, Israel

NCT04352439 COMPLETED

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Duke University

NCT04479579 COMPLETED

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

McMaster University

NCT04157881 COMPLETED

A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers

Population Health Research Institute

NCT03862755 COMPLETED

Chemoprophylaxis Plus Early Ambulation

Shen Lei

NCT04558125 TERMINATED

Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism

Cedars-Sinai Medical Center

NCT02412982 COMPLETED

Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

University of Cincinnati

NCT03988231 WITHDRAWN

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

University of Utah

NCT02396758 COMPLETED

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism

Boston Scientific Corporation

NCT03988842 TERMINATED

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism

Victor Tapson, MD

NCT03413618 COMPLETED

Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis

Pirogov Russian National Research Medical University

NCT02531581 COMPLETED

Diuretic Vascular Filling in the Initial Management of Acute PE With Right Ventricular Dysfunction Normotensive

Centre Hospitalier Universitaire de Nice

NCT03006562 TERMINATED

PREvention of VENous ThromboEmbolism Following Radical Prostatectomy

Johns Hopkins University

NCT03590743 TERMINATED

Calf Deep Vein Thrombosis Treatment Trial

Mayo Clinic

NCT02596555 TERMINATED

Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.

Prof. Stavros Konstantinides, MD

NCT02234375 WITHDRAWN

Use of Gadolinium in CT Pulmonary Angiography

Massachusetts General Hospital

NCT02958969 COMPLETED

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Gregory Piazza

NCT03196349 TERMINATED

Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism

Duke University

NCT02396732 TERMINATED

Aspirin and Enoxaparin for VTE in Trauma

University of Miami

NCT03081169 WITHDRAWN

Timing of VTE Prophylaxis in TBI

Loyola University

NCT02506985 TERMINATED

XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis

Susan Smyth

NCT02584660 COMPLETED

A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department

Janssen Scientific Affairs, LLC

NCT02644473 WITHDRAWN

Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients

Albert Einstein College of Medicine

NCT02376803 COMPLETED

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

University of Alberta

NCT03158792 COMPLETED

Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

Lebanese American University

NCT03027167 WITHDRAWN

Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty

Washington University School of Medicine

Data: ClinicalTrials.gov